Global Sepsis Biomarkers Market Growth (Status and Outlook) 2025-2031

September 2025 | 101 pages | ID: G89B22E97915EN
LP Information

Abstracts

According to this study, the global Sepsis Biomarkers market size will reach US$ 725 million by 2031.

Sepsis is an unusual systemic reaction to what is sometimes an otherwise ordinary infection, and it probably represents a pattern of response by the immune system to injury.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Sepsis Biomarkers Industry Forecast” looks at past sales and reviews total world Sepsis Biomarkers sales in 2024, providing a comprehensive analysis by region and market sector of projected Sepsis Biomarkers sales for 2025 through 2031. With Sepsis Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sepsis Biomarkers industry.

This Insight Report provides a comprehensive analysis of the global Sepsis Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sepsis Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sepsis Biomarkers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sepsis Biomarkers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sepsis Biomarkers.

This report presents a comprehensive overview, market shares, and growth opportunities of Sepsis Biomarkers market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Blood Biomarkers
• Urine Biomarkers

Segmentation by Application:

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermo Fisher Scientific
• Merck
• Bio-Rad Laboratories
• QIAGEN
• Roche
• Danaher Corporation
• Siemens Healthcare
• Abbott
• GenMark Diagnostics
• HiMedia Laboratories
• Immunexpress
• Abionic
• T2 Biosystems

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sepsis Biomarkers Market Size (2020-2031)
  2.1.2 Sepsis Biomarkers Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Sepsis Biomarkers by Country/Region (2020, 2024 & 2031)
2.2 Sepsis Biomarkers Segment by Type
  2.2.1 Blood Biomarkers
  2.2.2 Urine Biomarkers
2.3 Sepsis Biomarkers Market Size by Type
  2.3.1 Sepsis Biomarkers Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Sepsis Biomarkers Market Size Market Share by Type (2020-2025)
2.4 Sepsis Biomarkers Segment by Application
  2.4.1 Diagnostics
  2.4.2 Drug Discovery
  2.4.3 Personalized Medicine
  2.4.4 Others
2.5 Sepsis Biomarkers Market Size by Application
  2.5.1 Sepsis Biomarkers Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Sepsis Biomarkers Market Size Market Share by Application (2020-2025)

3 SEPSIS BIOMARKERS MARKET SIZE BY PLAYER

3.1 Sepsis Biomarkers Market Size Market Share by Player
  3.1.1 Global Sepsis Biomarkers Revenue by Player (2020-2025)
  3.1.2 Global Sepsis Biomarkers Revenue Market Share by Player (2020-2025)
3.2 Global Sepsis Biomarkers Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SEPSIS BIOMARKERS BY REGION

4.1 Sepsis Biomarkers Market Size by Region (2020-2025)
4.2 Global Sepsis Biomarkers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sepsis Biomarkers Market Size Growth (2020-2025)
4.4 APAC Sepsis Biomarkers Market Size Growth (2020-2025)
4.5 Europe Sepsis Biomarkers Market Size Growth (2020-2025)
4.6 Middle East & Africa Sepsis Biomarkers Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Sepsis Biomarkers Market Size by Country (2020-2025)
5.2 Americas Sepsis Biomarkers Market Size by Type (2020-2025)
5.3 Americas Sepsis Biomarkers Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sepsis Biomarkers Market Size by Region (2020-2025)
6.2 APAC Sepsis Biomarkers Market Size by Type (2020-2025)
6.3 APAC Sepsis Biomarkers Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sepsis Biomarkers Market Size by Country (2020-2025)
7.2 Europe Sepsis Biomarkers Market Size by Type (2020-2025)
7.3 Europe Sepsis Biomarkers Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sepsis Biomarkers by Region (2020-2025)
8.2 Middle East & Africa Sepsis Biomarkers Market Size by Type (2020-2025)
8.3 Middle East & Africa Sepsis Biomarkers Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SEPSIS BIOMARKERS MARKET FORECAST

10.1 Global Sepsis Biomarkers Forecast by Region (2026-2031)
  10.1.1 Global Sepsis Biomarkers Forecast by Region (2026-2031)
  10.1.2 Americas Sepsis Biomarkers Forecast
  10.1.3 APAC Sepsis Biomarkers Forecast
  10.1.4 Europe Sepsis Biomarkers Forecast
  10.1.5 Middle East & Africa Sepsis Biomarkers Forecast
10.2 Americas Sepsis Biomarkers Forecast by Country (2026-2031)
  10.2.1 United States Market Sepsis Biomarkers Forecast
  10.2.2 Canada Market Sepsis Biomarkers Forecast
  10.2.3 Mexico Market Sepsis Biomarkers Forecast
  10.2.4 Brazil Market Sepsis Biomarkers Forecast
10.3 APAC Sepsis Biomarkers Forecast by Region (2026-2031)
  10.3.1 China Sepsis Biomarkers Market Forecast
  10.3.2 Japan Market Sepsis Biomarkers Forecast
  10.3.3 Korea Market Sepsis Biomarkers Forecast
  10.3.4 Southeast Asia Market Sepsis Biomarkers Forecast
  10.3.5 India Market Sepsis Biomarkers Forecast
  10.3.6 Australia Market Sepsis Biomarkers Forecast
10.4 Europe Sepsis Biomarkers Forecast by Country (2026-2031)
  10.4.1 Germany Market Sepsis Biomarkers Forecast
  10.4.2 France Market Sepsis Biomarkers Forecast
  10.4.3 UK Market Sepsis Biomarkers Forecast
  10.4.4 Italy Market Sepsis Biomarkers Forecast
  10.4.5 Russia Market Sepsis Biomarkers Forecast
10.5 Middle East & Africa Sepsis Biomarkers Forecast by Region (2026-2031)
  10.5.1 Egypt Market Sepsis Biomarkers Forecast
  10.5.2 South Africa Market Sepsis Biomarkers Forecast
  10.5.3 Israel Market Sepsis Biomarkers Forecast
  10.5.4 Turkey Market Sepsis Biomarkers Forecast
10.6 Global Sepsis Biomarkers Forecast by Type (2026-2031)
10.7 Global Sepsis Biomarkers Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Sepsis Biomarkers Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific Sepsis Biomarkers Product Offered
  11.1.3 Thermo Fisher Scientific Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Merck
  11.2.1 Merck Company Information
  11.2.2 Merck Sepsis Biomarkers Product Offered
  11.2.3 Merck Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Merck Main Business Overview
  11.2.5 Merck Latest Developments
11.3 Bio-Rad Laboratories
  11.3.1 Bio-Rad Laboratories Company Information
  11.3.2 Bio-Rad Laboratories Sepsis Biomarkers Product Offered
  11.3.3 Bio-Rad Laboratories Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bio-Rad Laboratories Main Business Overview
  11.3.5 Bio-Rad Laboratories Latest Developments
11.4 QIAGEN
  11.4.1 QIAGEN Company Information
  11.4.2 QIAGEN Sepsis Biomarkers Product Offered
  11.4.3 QIAGEN Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 QIAGEN Main Business Overview
  11.4.5 QIAGEN Latest Developments
11.5 Roche
  11.5.1 Roche Company Information
  11.5.2 Roche Sepsis Biomarkers Product Offered
  11.5.3 Roche Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Roche Main Business Overview
  11.5.5 Roche Latest Developments
11.6 Danaher Corporation
  11.6.1 Danaher Corporation Company Information
  11.6.2 Danaher Corporation Sepsis Biomarkers Product Offered
  11.6.3 Danaher Corporation Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Danaher Corporation Main Business Overview
  11.6.5 Danaher Corporation Latest Developments
11.7 Siemens Healthcare
  11.7.1 Siemens Healthcare Company Information
  11.7.2 Siemens Healthcare Sepsis Biomarkers Product Offered
  11.7.3 Siemens Healthcare Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Siemens Healthcare Main Business Overview
  11.7.5 Siemens Healthcare Latest Developments
11.8 Abbott
  11.8.1 Abbott Company Information
  11.8.2 Abbott Sepsis Biomarkers Product Offered
  11.8.3 Abbott Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Abbott Main Business Overview
  11.8.5 Abbott Latest Developments
11.9 GenMark Diagnostics
  11.9.1 GenMark Diagnostics Company Information
  11.9.2 GenMark Diagnostics Sepsis Biomarkers Product Offered
  11.9.3 GenMark Diagnostics Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 GenMark Diagnostics Main Business Overview
  11.9.5 GenMark Diagnostics Latest Developments
11.10 HiMedia Laboratories
  11.10.1 HiMedia Laboratories Company Information
  11.10.2 HiMedia Laboratories Sepsis Biomarkers Product Offered
  11.10.3 HiMedia Laboratories Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 HiMedia Laboratories Main Business Overview
  11.10.5 HiMedia Laboratories Latest Developments
11.11 Immunexpress
  11.11.1 Immunexpress Company Information
  11.11.2 Immunexpress Sepsis Biomarkers Product Offered
  11.11.3 Immunexpress Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Immunexpress Main Business Overview
  11.11.5 Immunexpress Latest Developments
11.12 Abionic
  11.12.1 Abionic Company Information
  11.12.2 Abionic Sepsis Biomarkers Product Offered
  11.12.3 Abionic Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Abionic Main Business Overview
  11.12.5 Abionic Latest Developments
11.13 T2 Biosystems
  11.13.1 T2 Biosystems Company Information
  11.13.2 T2 Biosystems Sepsis Biomarkers Product Offered
  11.13.3 T2 Biosystems Sepsis Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 T2 Biosystems Main Business Overview
  11.13.5 T2 Biosystems Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Sepsis Biomarkers Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sepsis Biomarkers Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Blood Biomarkers
Table 4. Major Players of Urine Biomarkers
Table 5. Sepsis Biomarkers Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Sepsis Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Sepsis Biomarkers Market Size Market Share by Type (2020-2025)
Table 8. Sepsis Biomarkers Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Sepsis Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Sepsis Biomarkers Market Size Market Share by Application (2020-2025)
Table 11. Global Sepsis Biomarkers Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Sepsis Biomarkers Revenue Market Share by Player (2020-2025)
Table 13. Sepsis Biomarkers Key Players Head office and Products Offered
Table 14. Sepsis Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sepsis Biomarkers Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Sepsis Biomarkers Market Size Market Share by Region (2020-2025)
Table 19. Global Sepsis Biomarkers Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Sepsis Biomarkers Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Sepsis Biomarkers Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Sepsis Biomarkers Market Size Market Share by Country (2020-2025)
Table 23. Americas Sepsis Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Sepsis Biomarkers Market Size Market Share by Type (2020-2025)
Table 25. Americas Sepsis Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Sepsis Biomarkers Market Size Market Share by Application (2020-2025)
Table 27. APAC Sepsis Biomarkers Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Sepsis Biomarkers Market Size Market Share by Region (2020-2025)
Table 29. APAC Sepsis Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Sepsis Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Sepsis Biomarkers Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Sepsis Biomarkers Market Size Market Share by Country (2020-2025)
Table 33. Europe Sepsis Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Sepsis Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Sepsis Biomarkers Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Sepsis Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sepsis Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Sepsis Biomarkers
Table 39. Key Market Challenges & Risks of Sepsis Biomarkers
Table 40. Key Industry Trends of Sepsis Biomarkers
Table 41. Global Sepsis Biomarkers Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Sepsis Biomarkers Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Sepsis Biomarkers Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Sepsis Biomarkers Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Thermo Fisher Scientific Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 46. Thermo Fisher Scientific Sepsis Biomarkers Product Offered
Table 47. Thermo Fisher Scientific Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Thermo Fisher Scientific Main Business
Table 49. Thermo Fisher Scientific Latest Developments
Table 50. Merck Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 51. Merck Sepsis Biomarkers Product Offered
Table 52. Merck Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Merck Main Business
Table 54. Merck Latest Developments
Table 55. Bio-Rad Laboratories Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 56. Bio-Rad Laboratories Sepsis Biomarkers Product Offered
Table 57. Bio-Rad Laboratories Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bio-Rad Laboratories Main Business
Table 59. Bio-Rad Laboratories Latest Developments
Table 60. QIAGEN Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 61. QIAGEN Sepsis Biomarkers Product Offered
Table 62. QIAGEN Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. QIAGEN Main Business
Table 64. QIAGEN Latest Developments
Table 65. Roche Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 66. Roche Sepsis Biomarkers Product Offered
Table 67. Roche Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Roche Main Business
Table 69. Roche Latest Developments
Table 70. Danaher Corporation Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 71. Danaher Corporation Sepsis Biomarkers Product Offered
Table 72. Danaher Corporation Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Danaher Corporation Main Business
Table 74. Danaher Corporation Latest Developments
Table 75. Siemens Healthcare Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 76. Siemens Healthcare Sepsis Biomarkers Product Offered
Table 77. Siemens Healthcare Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Siemens Healthcare Main Business
Table 79. Siemens Healthcare Latest Developments
Table 80. Abbott Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 81. Abbott Sepsis Biomarkers Product Offered
Table 82. Abbott Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Abbott Main Business
Table 84. Abbott Latest Developments
Table 85. GenMark Diagnostics Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 86. GenMark Diagnostics Sepsis Biomarkers Product Offered
Table 87. GenMark Diagnostics Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. GenMark Diagnostics Main Business
Table 89. GenMark Diagnostics Latest Developments
Table 90. HiMedia Laboratories Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 91. HiMedia Laboratories Sepsis Biomarkers Product Offered
Table 92. HiMedia Laboratories Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. HiMedia Laboratories Main Business
Table 94. HiMedia Laboratories Latest Developments
Table 95. Immunexpress Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 96. Immunexpress Sepsis Biomarkers Product Offered
Table 97. Immunexpress Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Immunexpress Main Business
Table 99. Immunexpress Latest Developments
Table 100. Abionic Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 101. Abionic Sepsis Biomarkers Product Offered
Table 102. Abionic Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Abionic Main Business
Table 104. Abionic Latest Developments
Table 105. T2 Biosystems Details, Company Type, Sepsis Biomarkers Area Served and Its Competitors
Table 106. T2 Biosystems Sepsis Biomarkers Product Offered
Table 107. T2 Biosystems Sepsis Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. T2 Biosystems Main Business
Table 109. T2 Biosystems Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Sepsis Biomarkers Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sepsis Biomarkers Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sepsis Biomarkers Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sepsis Biomarkers Sales Market Share by Country/Region (2024)
Figure 8. Sepsis Biomarkers Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sepsis Biomarkers Market Size Market Share by Type in 2024
Figure 10. Sepsis Biomarkers in Diagnostics
Figure 11. Global Sepsis Biomarkers Market: Diagnostics (2020-2025) & ($ millions)
Figure 12. Sepsis Biomarkers in Drug Discovery
Figure 13. Global Sepsis Biomarkers Market: Drug Discovery (2020-2025) & ($ millions)
Figure 14. Sepsis Biomarkers in Personalized Medicine
Figure 15. Global Sepsis Biomarkers Market: Personalized Medicine (2020-2025) & ($ millions)
Figure 16. Sepsis Biomarkers in Others
Figure 17. Global Sepsis Biomarkers Market: Others (2020-2025) & ($ millions)
Figure 18. Global Sepsis Biomarkers Market Size Market Share by Application in 2024
Figure 19. Global Sepsis Biomarkers Revenue Market Share by Player in 2024
Figure 20. Global Sepsis Biomarkers Market Size Market Share by Region (2020-2025)
Figure 21. Americas Sepsis Biomarkers Market Size 2020-2025 ($ millions)
Figure 22. APAC Sepsis Biomarkers Market Size 2020-2025 ($ millions)
Figure 23. Europe Sepsis Biomarkers Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Sepsis Biomarkers Market Size 2020-2025 ($ millions)
Figure 25. Americas Sepsis Biomarkers Value Market Share by Country in 2024
Figure 26. United States Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Sepsis Biomarkers Market Size Market Share by Region in 2024
Figure 31. APAC Sepsis Biomarkers Market Size Market Share by Type (2020-2025)
Figure 32. APAC Sepsis Biomarkers Market Size Market Share by Application (2020-2025)
Figure 33. China Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 37. India Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Sepsis Biomarkers Market Size Market Share by Country in 2024
Figure 40. Europe Sepsis Biomarkers Market Size Market Share by Type (2020-2025)
Figure 41. Europe Sepsis Biomarkers Market Size Market Share by Application (2020-2025)
Figure 42. Germany Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 43. France Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Sepsis Biomarkers Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Sepsis Biomarkers Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Sepsis Biomarkers Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Sepsis Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 56. APAC Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 57. Europe Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 59. United States Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 60. Canada Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 61. Mexico Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 62. Brazil Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 63. China Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 64. Japan Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 65. Korea Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 67. India Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 68. Australia Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 69. Germany Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 70. France Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 71. UK Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 72. Italy Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 73. Russia Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 74. Egypt Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 75. South Africa Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 76. Israel Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 77. Turkey Sepsis Biomarkers Market Size 2026-2031 ($ millions)
Figure 78. Global Sepsis Biomarkers Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Sepsis Biomarkers Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Sepsis Biomarkers Market Size 2026-2031 ($ millions)